These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37301582)

  • 1. Questions about the BE OPTIMAL trial - Authors' reply.
    McInnes IB; Merola JF
    Lancet; 2023 Jun; 401(10392):1928. PubMed ID: 37301582
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions regarding the CONCERN trial - Authors' reply.
    Chan FKL; Ching JYL; Tse YK; Kyaw MH
    Lancet; 2018 Jan; 391(10116):121. PubMed ID: 29353616
    [No Abstract]   [Full Text] [Related]  

  • 3. Questions about the HELIX trial - Authors' reply.
    Thayyil S; Bassett P; Shankaran S
    Lancet Glob Health; 2021 Dec; 9(12):e1654-e1655. PubMed ID: 34798023
    [No Abstract]   [Full Text] [Related]  

  • 4. Questions about the BE COMPLETE trial - Authors' reply.
    Merola JF; McInnes IB
    Lancet; 2023 Jun; 401(10392):1927. PubMed ID: 37301581
    [No Abstract]   [Full Text] [Related]  

  • 5. DESTINY-Breast03 trial: some questions remain - Authors' reply.
    Hurvitz SA; Curigliano G; Egorov A; Ashfaque S; Cortés J
    Lancet; 2023 May; 401(10389):1653-1654. PubMed ID: 37210117
    [No Abstract]   [Full Text] [Related]  

  • 6. EFFORT Protein trial: questions remain - Authors' reply.
    Patel JJ; Lee ZY; Stoppe C; Heyland DK
    Lancet; 2023 Sep; 402(10406):964. PubMed ID: 37716768
    [No Abstract]   [Full Text] [Related]  

  • 7. The REVAMP trial: key questions remain - Authors' reply.
    Pasricha SR; Moya E; Ataide R; Mzembe G; Harding R; Phiri K
    Lancet; 2024 Jan; 403(10421):29-30. PubMed ID: 38184336
    [No Abstract]   [Full Text] [Related]  

  • 8. Questions about the BEST-Fluids trial - Authors' reply.
    Collins MG; Fahim MA; Hawley CM; Johnson DW; Chadban SJ
    Lancet; 2024 Mar; 403(10430):911-912. PubMed ID: 38460988
    [No Abstract]   [Full Text] [Related]  

  • 9. Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply.
    Bhatt DL; Bakris GL
    Lancet; 2023 Apr; 401(10385):1337-1338. PubMed ID: 37087166
    [No Abstract]   [Full Text] [Related]  

  • 10. Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.
    Meinel AB; Meinel MP
    Appl Opt; 1985 Apr; 24(7):944. PubMed ID: 20436652
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV treatment-as-prevention research: authors' reply.
    Bärnighausen T; Eyal N; Wikler D
    PLoS Med; 2015 Mar; 12(3):e1001799. PubMed ID: 25756214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health of migrants: simple questions can improve care - Authors' reply.
    Abubakar I; Miranda JJ; Barreto ML; Orcutt M; Devakumar D;
    Lancet; 2019 Jun; 393(10188):2298-2299. PubMed ID: 31122663
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity and the nervous system: more questions - Authors' reply.
    Callaghan BC; O'Brien PD; Hinder LM; Feldman EL
    Lancet Neurol; 2017 Oct; 16(10):774. PubMed ID: 28920882
    [No Abstract]   [Full Text] [Related]  

  • 14. Questions in the design of ANSWER - Authors' reply.
    Caraceni P; Roncadori A; Bernardi M;
    Lancet; 2018 Nov; 392(10158):1623-1624. PubMed ID: 30496075
    [No Abstract]   [Full Text] [Related]  

  • 15. The Lancet COPD Commission: broader questions remain - Authors' reply.
    Dransfield MT; Stolz D
    Lancet; 2023 May; 401(10388):1570. PubMed ID: 37179115
    [No Abstract]   [Full Text] [Related]  

  • 16. Answer for questions of repeated measurements of variance analysis and distribution test of data - Authors' reply.
    Wang DW; Ni L; Jiang H
    Front Med; 2022 Aug; 16(4):661-665. PubMed ID: 35776404
    [No Abstract]   [Full Text] [Related]  

  • 17. GBD 2019 study informs industry yet crucial questions remain unanswered - Authors' reply.
    Stanaway JD; Hay SI; Murray CJL;
    Lancet; 2023 Mar; 401(10378):731-732. PubMed ID: 36870726
    [No Abstract]   [Full Text] [Related]  

  • 18. The arrhythmic risk in Kearns-Sayre syndrome: still many questions unanswered-Authors' reply.
    Di Mambro C; Tamborrino PP; Drago F
    Europace; 2021 Jun; 23(6):981-982. PubMed ID: 33880526
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis control: hard questions - Authors' reply.
    Khan MS; Coker RJ
    Lancet; 2014 Nov; 384(9956):1744-5. PubMed ID: 25455241
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of antibiotic pairs with disjoint resistance: innovative progress made but questions remain - Authors' reply.
    Wright ES; Beckley A
    Lancet Microbe; 2021 Dec; 2(12):e653. PubMed ID: 35544105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.